DexCom, Inc., the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects with the t:slim X2™ insulin pump by Tandem Diabetes Care in the United States, marking the first AID integration with the Dexcom G7 CGM, the world’s most accurate1,2 CGM system.
Zepp Health Corporation, a global leader in smart wearables and health technology, commemorates its 10th anniversary with a brand refresh.
The Biospectal OptiBP app is the first and only software-only blood pressure monitoring solution on smartphones to receive the CE Mark, democratizing worldwide access to easy, connected blood pressure management to combat hypertension, the world’s num...
In an era where technological advancements drive transformative changes across industries, the pharma industry is witnessing a significant shift towar…
DUOS, a digital health company empowering older adults to live independently and attain the highest level of health in partnership with health plans, today announced the launch of its latest initiative, Connections for a Cause.
Verato, the identity experts for healthcare, today announced that UofL Health, a fully integrated regional academic health system, will partner with Verato to deploy Verato’s healthcare master data management (hMDM) solution to support accurate identity management across UofL Health’s entire enterprise.
Eligo Bioscience, a pioneering gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, has announced a successful $30 million Series B funding round, led by Sanofi Ventures.
The global healthcare problem faced by Alzheimer's disease (AD), which is characterized by progressive cognitive decline, memory loss, and behavioral …
Rainbird Technologies and Klick Health today announced an exclusive, new partnership that will bring Rainbird’s proven Decision Intelligence platform to life sciences companies across North America, reinforcing both companies’ success working in highly regulated industries.
Artificial Intelligence (AI)-driven Primary Care company K Health announces today the publication of its peer-reviewed research in Mayo Clinic Proceedings: Digital Health, which demonstrates how K Health’s AI can provide information that allows for more personalized hypertension treatment in patient-facing settings.